DES Holdings (08437) announced that on March 21, 2024, the company is a wholly-owned subsidiary of DES Hong Kong and T...
According to Zhitong Finance App, Des Holdings (08437) issued an announcement. On March 21, 2024, the company's wholly-owned subsidiary Des Hong Kong and Ms. Tse (the current shareholder of Huangren Medical) entered into a shareholder agreement with Huangren Healthcare to regulate the management and operation arrangements of Huangren Healthcare and the respective rights and obligations of Des Hong Kong and Ms. Tse.
The conclusion of a shareholder agreement is the first step for the Group to implement new business plans and strategies to continue and revitalize the Group's healthcare services business segment. After concluding a shareholder agreement and appointing Mr. Pan and Mr. Lu as directors of Huangren Medical, the Group will have control of Huangren Medical's board of directors. Huangren Medical will be recorded as a subsidiary of the Group, and Huangren Medical's financial performance, assets and liabilities will be comprehensively incorporated into the Group's financial statements. In the future, the Group will focus on promoting and developing the healthcare service business in Hong Kong through Huangren Healthcare.
Chairman of the Board and Executive Director Mr. Pan has extensive experience in healthcare and education. He has founded an education centre, a medical clinic and a Chinese medicine clinic in Hong Kong. He will be responsible for overseeing the management, business development and operation of Huangren Medical. With his past knowledge and experience in the medical industry, he will be able to provide the Group with valuable strategic and development guidance and advice to help the Group operate its healthcare services business segment to seize Hong Kong's growing demand for healthcare services, bring stable revenue to the Group, and enhance long-term returns to shareholders.